10100
0
Posted on Aug 12, 2008, 8 p.m.
By Jeanelle Topping
Male prostate cancer patients who receive radical prostatectomy demonstrate a lower death rate, it has been claimed.
Male prostate cancer patients who receive radical prostatectomy demonstrate a lower death rate, it has been claimed.
This is in comparison to men who do not undergo treatment, which is known as watchful waiting, Eurekalert notes.
The results come following a randomized controlled trial published in the August 12th online issue of the Journal of the National Cancer Institute.
Although the overall mortality rate among the two groups was not "statistically different", men who had had the surgery demonstrated its benefits for over ten years.
The Scandinavian Prostate Cancer Group began the trail in 1989 and discovered that men in the prostatectomy group had lower rates of disease-specific death when their cases were followed up.
However, the authors noted: "Contrary to our predictions based on shorter follow-up, the absolute difference in cumulative incidence of distant metastasis and prostate cancer death did not further increase after seven years of follow-up."
In related news that may be of interest to anti-aging physicians, researchers at the University of Manchester have unveiled a 3D structure of a protein responsible for regulating chromosome numbers during cell division which they say will be essential in the prevention of the disease.
